New Hampshire Trust Cuts Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

New Hampshire Trust trimmed its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 949 shares of the medical equipment provider’s stock after selling 28 shares during the period. New Hampshire Trust’s holdings in Intuitive Surgical were worth $379,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the business. Kestra Advisory Services LLC raised its stake in shares of Intuitive Surgical by 4.6% during the third quarter. Kestra Advisory Services LLC now owns 12,910 shares of the medical equipment provider’s stock valued at $3,773,000 after acquiring an additional 563 shares during the last quarter. Stokes Family Office LLC raised its stake in shares of Intuitive Surgical by 5.1% during the third quarter. Stokes Family Office LLC now owns 1,212 shares of the medical equipment provider’s stock valued at $354,000 after acquiring an additional 59 shares during the last quarter. V Square Quantitative Management LLC raised its stake in shares of Intuitive Surgical by 65.4% during the third quarter. V Square Quantitative Management LLC now owns 1,394 shares of the medical equipment provider’s stock valued at $407,000 after acquiring an additional 551 shares during the last quarter. Dark Forest Capital Management LP raised its stake in shares of Intuitive Surgical by 66.6% during the third quarter. Dark Forest Capital Management LP now owns 1,306 shares of the medical equipment provider’s stock valued at $382,000 after acquiring an additional 522 shares during the last quarter. Finally, LPL Financial LLC raised its stake in shares of Intuitive Surgical by 14.2% during the third quarter. LPL Financial LLC now owns 210,938 shares of the medical equipment provider’s stock valued at $61,679,000 after acquiring an additional 26,164 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Trading Down 0.6 %

Shares of ISRG stock opened at $432.55 on Friday. Intuitive Surgical, Inc. has a 12-month low of $254.85 and a 12-month high of $437.20. The firm’s 50 day moving average is $396.18 and its 200 day moving average is $377.36. The stock has a market capitalization of $153.43 billion, a P/E ratio of 78.08, a P/E/G ratio of 5.62 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The company had revenue of $1.89 billion for the quarter, compared to analysts’ expectations of $1.87 billion. During the same quarter last year, the company posted $1.00 earnings per share. The firm’s quarterly revenue was up 11.5% on a year-over-year basis. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on ISRG. Piper Sandler upped their price objective on shares of Intuitive Surgical from $425.00 to $435.00 and gave the company an “overweight” rating in a research note on Friday, April 19th. Jefferies Financial Group increased their price target on shares of Intuitive Surgical from $365.00 to $375.00 and gave the stock a “hold” rating in a research note on Friday, April 19th. Citigroup increased their price target on shares of Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. StockNews.com downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Thursday, February 29th. Finally, Stifel Nicolaus raised their target price on shares of Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, April 8th. Five investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average price target of $403.67.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Craig H. Barratt sold 1,400 shares of the stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $421.06, for a total value of $589,484.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other news, Director Craig H. Barratt sold 1,400 shares of the firm’s stock in a transaction on Wednesday, June 12th. The shares were sold at an average price of $421.06, for a total transaction of $589,484.00. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Alan J. Levy sold 2,000 shares of the firm’s stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $370.70, for a total transaction of $741,400.00. Following the sale, the director now owns 25,319 shares in the company, valued at $9,385,753.30. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 17,956 shares of company stock worth $6,927,011. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.